ConductScience.org, home

Paper33396604

Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.

Tsukigawa K and 7 others. Pharmaceuticals (Basel), 2020. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin. Papers, record 33396604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33396604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2021-02-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsukigawa KKenji
2Imoto SShuhei
3Yamasaki KKeishihttps://orcid.org/0000-0003-0537-2367
4Nishi KKojihttps://orcid.org/0000-0002-7561-5320
5Tsutsumi TToshihiko
6Yokoyama SShoko
7Ishima YYuhttps://orcid.org/0000-0002-5359-3722
8Otagiri MMasaki

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
19K16467Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12692843Tumoritropic and lymphotropic principles of macromolecular drugs.Crit Rev Ther Drug Carrier Syst1989https://conductscience.org/library/papers/2692843PubMed
230503561Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.Acta Biomater2019https://conductscience.org/library/papers/30503561PubMed
36526737Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.J Antibiot (Tokyo)1984https://conductscience.org/library/papers/6526737PubMed
418582981Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.J Control Release2008https://conductscience.org/library/papers/18582981PubMed
59353418Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners.J Pharmacol Exp Ther1997https://conductscience.org/library/papers/9353418PubMed
629109768Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.Theranostics2017https://conductscience.org/library/papers/29109768PubMed
722225412S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects.Bioconjug Chem2012https://conductscience.org/library/papers/22225412PubMed
821839127Albumin-based nanoparticles as potential controlled release drug delivery systems.J Control Release2012https://conductscience.org/library/papers/21839127PubMed
98675628Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide.J Clin Invest1995https://conductscience.org/library/papers/8675628PubMed
106016603Removal of fatty acids from serum albumin by charcoal treatment.J Biol Chem1967https://conductscience.org/library/papers/6016603PubMed
116833151Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.J Antibiot (Tokyo)1983https://conductscience.org/library/papers/6833151PubMed
1227111654Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.Adv Mater2016https://conductscience.org/library/papers/27111654PubMed
1324846171Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicine.J Pharm Sci2014https://conductscience.org/library/papers/24846171PubMed
1417869367Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.J Control Release2007https://conductscience.org/library/papers/17869367PubMed
1524709221Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?Int J Pharm2014https://conductscience.org/library/papers/24709221PubMed
1623423979Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.Cancer Res2013https://conductscience.org/library/papers/23423979PubMed
17528373Tetrahydropyranyl derivatives of daunomycin and adriamycin.J Antibiot (Tokyo)1979https://conductscience.org/library/papers/528373PubMed
1820840859A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.Adv Drug Deliv Rev2011https://conductscience.org/library/papers/20840859PubMed
1927934482Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.Mol Pharm2016https://conductscience.org/library/papers/27934482PubMed
208640796Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.Cancer Res1996https://conductscience.org/library/papers/8640796PubMed

See all 35 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41872646Mechanistic Insights into pH-Responsive Drug Release and Antitumor Effects of an Albumin-Pirarubicin Conjugate.Pharm Res2026https://conductscience.org/library/papers/41872646PubMed
35720996Chemical Conjugation in Drug Delivery Systems.Front Chem2022https://conductscience.org/library/papers/35720996PubMed
33810483When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/33810483PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
GLI22736PubTator's text mininghttps://conductscience.org/library/genes/2736NCBI Gene
UMOD7369PubTator's text mininghttps://conductscience.org/library/genes/7369NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33396604

GET https://conductscience.org/api/papers/v1/33396604/references?page=2